Nasal congestion: FDA reporting patterns
57,766 FDA FAERS reports mention Nasal congestion. 24,788 reports have a serious outcome flag.
Medicines named as suspect
- Dupilumab: 4,526 reports
- Ambrisentan: 3,279 reports
- Adalimumab: 3,192 reports
- Etanercept: 3,115 reports
- Treprostinil: 2,228 reports
- Omalizumab: 2,124 reports
- Fluticasone: 1,983 reports
- Infliximab: 1,731 reports
- Albuterol: 1,594 reports
- Macitentan: 1,538 reports
- Budesonide: 1,456 reports
- Ritonavir: 1,425 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.